| Catalog Number |
1021720000 |
| Medical Device Problem Code |
False Negative Result (1225)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/29/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that the sample (b)(6), from "memorial blood center", was tested with serology.The test result was positive (c+), which contrasted with the molecular typing performed on (b)(6) 2023, using the id core xt assay which provided negative results (c-), with id core xt analysis software v3.0.4.1.
|
| |
|
Additional Manufacturer Narrative
|
|
See section b6.
|
| |
|
Additional Manufacturer Narrative
|
|
The genomic dna sample was sent to grifols laboratory solution for next generation sequencing (ngs) of the rh exons 1-10 and portions of introns 2 and 3.The allele rhce*diiia(1-2)-cevs.03 was identified.The intron 2 insert is not present indicating absence of the consensus rhce*ce allele as reported by id core xt.This new allele, not previously described by isbt, could be associated with partial c expression, in agreement with the reported c+ serotyping.Id core xt reported a predicted c- phenotype, but rhce*diiia(1-2)-cevs.03 not interrogated by id core xt, is associated with partial c+ phenotype.This false negative result obtained by id core xt is considered a discrepant result and then a malfunction.This limitation is covered by the general assay limitations described in the id core xt package insert (limitations 1 and 9).
|
| |
|
Search Alerts/Recalls
|